Mahesh Karande - Jul 29, 2021 Form 3 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
President and CEO, Director, 10%+ Owner
Signature
/s/ Barbara Chan as Attorney-in-fact for Mahesh Karande
Stock symbol
OMGA
Transactions as of
Jul 29, 2021
Transactions value $
$0
Form type
3
Date filed
7/29/2021, 09:02 PM
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OMGA Common Stock 106K Jul 29, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMGA Stock Option (Right to Buy) Jul 29, 2021 Common Stock 895K $0.53 Direct F1
holding OMGA Stock Option (Right to Buy) Jul 29, 2021 Common Stock 326K $0.60 Direct F1
holding OMGA Stock Option (Right to Buy) Jul 29, 2021 Common Stock 938K $5.67 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable with respect to 25% of the underlying shares on April 1, 2020 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on April 1, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date.
F2 The options vest and become exercisable with respect to 25% of the underlying shares on March 26, 2022 and in equal quarterly installments thereafter such that the option will become fully vested and exercisable on March 26, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Remarks:

Exhibit 24 - Power of Attorney.